The Cooper Companies, Inc. COO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Cooper Companies, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Cooper Companies, Inc.'s cash & equivalents?
- The Cooper Companies, Inc. (COO) reported cash & equivalents of $139M in Q1 2026.
- How has The Cooper Companies, Inc.'s cash & equivalents changed year-over-year?
- The Cooper Companies, Inc.'s cash & equivalents increased by 19.6% year-over-year, from $116.2M to $139M.
- What is the long-term trend for The Cooper Companies, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), The Cooper Companies, Inc.'s cash & equivalents has grown at a -1.1% compound annual growth rate (CAGR), from $116.8M to $110.6M.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid investments the company has on hand.
- How do you interpret cash & equivalents?
- An increase suggests strong liquidity and potential for investment, while a decrease may indicate heavy capital expenditure or cash burn.
- How does cash & equivalents compare across companies?
- Standard across all public companies; peers in medical devices typically maintain moderate cash buffers.